What are the FDA label indications for Guanfacine?

What are the FDA label indications for Guanfacine?

• A. Chronic pain; diabetes
• B. ADHD; hypertension
• C. Anxiety; depression
• D. Heart failure; arrhythmias

Answer: (B)

The FDA label indications for Guanfacine include its use in the treatment of ADHD (Attention Deficit Hyperactivity Disorder) and hypertension. Guanfacine is an alpha-2 adrenergic agonist that works by affecting receptors in the brain, which helps to improve attention and focus in individuals with ADHD, as well as reducing blood pressure by calming the nervous system's response. The use for ADHD is particularly important as Guanfacine is often prescribed as part of a broader treatment plan for children and adolescents who display symptoms of hyperactivity and impulsivity. Additionally, its indication for hypertension highlights its role in managing high blood pressure, making it valuable for patients who may require control over their blood pressure levels through a non-stimulant medication. The other options do not pertain to the FDA-approved uses for Guanfacine; it is not indicated for chronic pain or diabetes, anxiety, depression, heart failure, or arrhythmias. This specificity in use underscores the importance of understanding the correct applications of medications and their therapeutic targets.

The FDA label indications for Guanfacine include its use in the treatment of ADHD (Attention Deficit Hyperactivity Disorder) and hypertension. Guanfacine is an alpha-2 adrenergic agonist that works by affecting receptors in the brain, which helps to improve attention and focus in individuals with ADHD, as well as reducing blood pressure by calming the nervous system's response.

The use for ADHD is particularly important as Guanfacine is often prescribed as part of a broader treatment plan for children and adolescents who display symptoms of hyperactivity and impulsivity. Additionally, its indication for hypertension highlights its role in managing high blood pressure, making it valuable for patients who may require control over their blood pressure levels through a non-stimulant medication.

The other options do not pertain to the FDA-approved uses for Guanfacine; it is not indicated for chronic pain or diabetes, anxiety, depression, heart failure, or arrhythmias. This specificity in use underscores the importance of understanding the correct applications of medications and their therapeutic targets.